HistoRx is a medical device and diagnostics company that improves efficiency and effectiveness across the entire drug development continuum by providing the first advanced platform capable of measuring biomarker concentration with sub-cellular resolution in tissue sections. HistoRx services and products are used throughout biomedical research and pre-clinical and clinical drug development.
ocation: New Haven, Connecticut
Commons Capital’s co-investors include:
Brook Ventures, Navigator Technology Ventures (Draper Laboratories), Maven Biocapital and Roche Ventures